Starr Kevin P - Insider Stock Trading - OpenInsider

CIK: 1192603 - Address: C/o Sage Therapeutics, Inc., 215 First Street, Cambridge, MA 02142

19 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	7	1	9	-2	-4	-7	15	30	13	7
S	%wins				78	89	50	38	33	50	56

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
6/17/21 09:15	6/16/21	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		P	1,000	56.05	0	18	6	321	D
2/14/19 17:45	2/12/19	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S	0	0.00	0	0	0	303	I
4/19/18 16:35	4/17/18	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S.m	-9,962	168.85	0	-59	-15	340	D
1/5/18 16:30	1/3/18	MYOK	Myokardia Inc	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	CA	DT		S	-34,286	42.00	0	-816	-50	826	I
10/4/17 16:00	10/3/17	MYOK	Myokardia Inc	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	CA	DT		S	-3,034	40.28	0	-75	-1	6,452	D
9/27/17 16:00	9/25/17	MYOK	Myokardia Inc	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	CA	DT		S.m	-25,860	43.00	0	-601	-8	6,963	I
9/12/17 16:05	9/8/17	MYOK	Myokardia Inc	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	CA	DT		S	-8,252	41.01	0	-201	-3	7,564	I
4/14/17 16:00	4/12/17	CTMX	Cytomx Therapeutics, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	T		S	-464	16.36	9	-28	-1	5,202	D		15	19	37	1	-12	-11	-6	-2	2
12/21/16 18:44	12/19/16	BPMC	Blueprint Medicines Corp	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	T		S	-3,002	28.19	13	-106	-2	5,454	D		16	54	-1	-2	-2	7	7	-5	-1	13	44
12/20/16 17:46	12/16/16	GBT	Global Blood Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	T		S	-1,743	16.00	12	-109	-1	8,843	D		-47	-10	-30	-3	-14	-1	0	-6	-11	3	135
9/7/16 16:05	9/6/16	EDIT	Editas Medicine, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Starr Kevin P	MA	T		S	-94	15.90	7	-6	0	3,906	D			-62	-52	-41	-20	-13	-5	4	-7	-7	-5	33
5/18/16 16:24	5/16/16	SAGE	Sage Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	DT		S	-26,563	31.25	14	-850	-18	3,958	I		-46	-27	-6	-15	-13	-6	1	-4	-3	-8	14	72
11/13/15 16:36	11/11/15	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		M.dm	911	12.15	33	75		0	D	83	-1	-17	-6	19	24	6	-9	-1	0	-14	-39	-49	-57
11/13/15 16:36	11/11/15	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S.dm	-7,792	103.90	33	-75	-100	0	D	83	-1	-17	-6	19	24	6	-9	-1	0	-14	-39	-49	-57
9/25/15 16:38	9/24/15	ZFGN	Zafgen, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S	-5,995	43.90	11	-137	-27	370	M		105	-2	13	11	10	1	-8	-8	-12	-65	-73	-76	-82
9/26/14 16:31	9/24/14	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		M.dm	1,516	16.85	33	90		0	D	295	23	19	21	16	19	6	0	0	-4	19	19	33	6
9/26/14 16:31	9/24/14	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S.dm	-7,028	78.09	33	-90	-100	0	D	295	23	19	21	16	19	6	0	0	-4	19	19	33	6
3/26/13 18:53	3/25/13	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		M.dm	50	0.9500	11	53		0	D	140	106	19	26	-4	-7	-6	-3	2	0	1	25	168	184
3/26/13 18:53	3/25/13	ALNY	Alnylam Pharmaceuticals, Inc.		Health	Drug	Pharmaceutical Preparations	Starr Kevin P	MA	D		S.dm	-1,236	23.49	11	-53	-100	0	D	140	106	19	26	-4	-7	-6	-3	2	0	1	25	168	184

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact